wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48295756-CB9CFF2C-C139-4916-A9C6-48ECF77BE074
Q48295756-CB9CFF2C-C139-4916-A9C6-48ECF77BE074
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48295756-CB9CFF2C-C139-4916-A9C6-48ECF77BE074
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study.
P2860
Q48295756-CB9CFF2C-C139-4916-A9C6-48ECF77BE074
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48295756-CB9CFF2C-C139-4916-A9C6-48ECF77BE074
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7eeab6fb8b40e5f004f6a0228a8c566ca007853f
P2860
Patient-relevant treatment goals in psoriasis.